Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| African Americans | 14 | 2014 | 264 | 2.270 |
Why?
|
| Aged | 21 | 2014 | 1539 | 0.920 |
Why?
|
| Aged, 80 and over | 16 | 2014 | 497 | 0.800 |
Why?
|
| Male | 21 | 2014 | 3671 | 0.670 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2003 | 8 | 0.650 |
Why?
|
| Retrospective Studies | 12 | 2014 | 681 | 0.620 |
Why?
|
| Humans | 28 | 2014 | 6794 | 0.620 |
Why?
|
| Female | 20 | 2014 | 4060 | 0.590 |
Why?
|
| Adult | 14 | 2014 | 2113 | 0.590 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2005 | 25 | 0.530 |
Why?
|
| Middle Aged | 14 | 2014 | 2108 | 0.510 |
Why?
|
| Hepatitis C | 2 | 2006 | 19 | 0.470 |
Why?
|
| Diarrhea | 2 | 2007 | 10 | 0.460 |
Why?
|
| Colonoscopy | 3 | 2011 | 10 | 0.450 |
Why?
|
| Pancreatitis | 2 | 2007 | 108 | 0.440 |
Why?
|
| Choledocholithiasis | 1 | 2014 | 1 | 0.430 |
Why?
|
| Pain Measurement | 1 | 2014 | 51 | 0.420 |
Why?
|
| Gastrointestinal Diseases | 2 | 2003 | 8 | 0.390 |
Why?
|
| Hepatic Encephalopathy | 2 | 2002 | 2 | 0.370 |
Why?
|
| Mallory-Weiss Syndrome | 1 | 2011 | 1 | 0.350 |
Why?
|
| Conscious Sedation | 1 | 2011 | 3 | 0.340 |
Why?
|
| United States | 8 | 2011 | 1019 | 0.340 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 23 | 0.330 |
Why?
|
| Treatment Outcome | 2 | 2014 | 500 | 0.320 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2007 | 65 | 0.310 |
Why?
|
| Frail Elderly | 3 | 2005 | 9 | 0.300 |
Why?
|
| Jaundice | 1 | 2007 | 3 | 0.270 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 8 | 0.270 |
Why?
|
| Risk Factors | 5 | 2011 | 767 | 0.270 |
Why?
|
| Prevalence | 5 | 2007 | 259 | 0.270 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2007 | 2 | 0.260 |
Why?
|
| Proton Pump Inhibitors | 1 | 2007 | 2 | 0.260 |
Why?
|
| Cross Infection | 1 | 2007 | 12 | 0.260 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2006 | 2 | 0.250 |
Why?
|
| Colonic Diseases | 1 | 2006 | 3 | 0.250 |
Why?
|
| Nursing Homes | 2 | 2005 | 8 | 0.250 |
Why?
|
| Colon | 1 | 2006 | 20 | 0.250 |
Why?
|
| Metabolic Syndrome | 1 | 2006 | 35 | 0.240 |
Why?
|
| Los Angeles | 5 | 2011 | 321 | 0.240 |
Why?
|
| Comorbidity | 4 | 2011 | 147 | 0.230 |
Why?
|
| Interferon-alpha | 1 | 2005 | 2 | 0.230 |
Why?
|
| Arthritis, Infectious | 1 | 2005 | 3 | 0.230 |
Why?
|
| Age Factors | 3 | 2014 | 193 | 0.230 |
Why?
|
| Antiviral Agents | 1 | 2005 | 53 | 0.230 |
Why?
|
| Fecal Incontinence | 1 | 2005 | 4 | 0.220 |
Why?
|
| Dyspepsia | 1 | 2004 | 2 | 0.210 |
Why?
|
| Liver Diseases | 2 | 2011 | 19 | 0.210 |
Why?
|
| Succimer | 1 | 2003 | 1 | 0.210 |
Why?
|
| Lead Poisoning | 1 | 2003 | 5 | 0.200 |
Why?
|
| Esophageal Diseases | 1 | 2003 | 1 | 0.200 |
Why?
|
| Wounds, Gunshot | 1 | 2003 | 15 | 0.200 |
Why?
|
| Chelating Agents | 1 | 2003 | 13 | 0.200 |
Why?
|
| Colonic Polyps | 1 | 2003 | 1 | 0.200 |
Why?
|
| Esophagus | 1 | 2003 | 13 | 0.200 |
Why?
|
| Administration, Oral | 1 | 2003 | 54 | 0.200 |
Why?
|
| Skin Diseases | 1 | 2003 | 6 | 0.200 |
Why?
|
| Syphilis | 1 | 2003 | 5 | 0.200 |
Why?
|
| Myocardial Infarction | 2 | 2002 | 46 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 9 | 0.190 |
Why?
|
| Minority Groups | 1 | 2003 | 63 | 0.190 |
Why?
|
| Urban Population | 3 | 2014 | 85 | 0.190 |
Why?
|
| HIV Infections | 2 | 2007 | 432 | 0.190 |
Why?
|
| Conjunctival Diseases | 1 | 2002 | 5 | 0.180 |
Why?
|
| Liver Failure | 1 | 2002 | 3 | 0.180 |
Why?
|
| Edema | 1 | 2002 | 6 | 0.180 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2011 | 6 | 0.180 |
Why?
|
| Young Adult | 2 | 2014 | 567 | 0.160 |
Why?
|
| Rectum | 1 | 2000 | 8 | 0.160 |
Why?
|
| Physical Examination | 1 | 2000 | 7 | 0.160 |
Why?
|
| Abdominal Pain | 2 | 2014 | 15 | 0.160 |
Why?
|
| Odds Ratio | 2 | 2014 | 82 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2014 | 197 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2014 | 285 | 0.140 |
Why?
|
| California | 2 | 2014 | 230 | 0.140 |
Why?
|
| Hospitals, Urban | 2 | 2011 | 10 | 0.140 |
Why?
|
| Adolescent | 2 | 2011 | 869 | 0.120 |
Why?
|
| Acute Disease | 2 | 2007 | 91 | 0.120 |
Why?
|
| Biomarkers | 2 | 2007 | 214 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2007 | 108 | 0.110 |
Why?
|
| Biliary Tract | 1 | 2014 | 2 | 0.110 |
Why?
|
| Cholecystectomy | 1 | 2014 | 4 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2014 | 6 | 0.110 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 8 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2014 | 17 | 0.110 |
Why?
|
| Algorithms | 2 | 2005 | 83 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 118 | 0.100 |
Why?
|
| Sex Factors | 1 | 2014 | 155 | 0.100 |
Why?
|
| Age Distribution | 2 | 2003 | 45 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 268 | 0.100 |
Why?
|
| Prognosis | 2 | 2003 | 220 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 42 | 0.090 |
Why?
|
| Cholestasis | 1 | 2011 | 7 | 0.090 |
Why?
|
| Recurrence | 1 | 2011 | 55 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 7 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2007 | 4 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 49 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 73 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2006 | 17 | 0.060 |
Why?
|
| Hospitalization | 1 | 2007 | 128 | 0.060 |
Why?
|
| Arthralgia | 1 | 2005 | 3 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2005 | 20 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 145 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 45 | 0.060 |
Why?
|
| Inflammation | 1 | 2006 | 143 | 0.060 |
Why?
|
| Gallstones | 1 | 2004 | 6 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 7 | 0.050 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2004 | 28 | 0.050 |
Why?
|
| Radiography | 1 | 2004 | 20 | 0.050 |
Why?
|
| Pregnancy | 1 | 2006 | 599 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sigmoidoscopy | 1 | 2003 | 2 | 0.050 |
Why?
|
| Decision Trees | 1 | 2003 | 6 | 0.050 |
Why?
|
| Resuscitation | 1 | 2003 | 6 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 2003 | 1 | 0.050 |
Why?
|
| Lead | 1 | 2003 | 5 | 0.050 |
Why?
|
| Antacids | 1 | 2003 | 1 | 0.050 |
Why?
|
| Protons | 1 | 2003 | 1 | 0.050 |
Why?
|
| Sucralfate | 1 | 2003 | 1 | 0.050 |
Why?
|
| Histamine H2 Antagonists | 1 | 2003 | 2 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2003 | 4 | 0.050 |
Why?
|
| Endoscopy | 1 | 2003 | 7 | 0.050 |
Why?
|
| Patient Selection | 1 | 2003 | 40 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2003 | 44 | 0.050 |
Why?
|
| Coinfection | 1 | 2003 | 4 | 0.050 |
Why?
|
| Preventive Health Services | 1 | 2003 | 21 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2003 | 30 | 0.050 |
Why?
|
| Infection Control | 1 | 2003 | 8 | 0.050 |
Why?
|
| Life Style | 1 | 2003 | 51 | 0.050 |
Why?
|
| Incidence | 1 | 2003 | 197 | 0.050 |
Why?
|
| Time Factors | 1 | 2003 | 321 | 0.050 |
Why?
|
| Meningitis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cellulitis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pneumonia | 1 | 2002 | 4 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Peritonitis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Medical Records | 1 | 2002 | 23 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2002 | 10 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2002 | 9 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 79 | 0.050 |
Why?
|
| Medical Audit | 1 | 2002 | 12 | 0.050 |
Why?
|
| Stroke | 1 | 2002 | 46 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 65 | 0.040 |
Why?
|
| Safety | 1 | 2000 | 18 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 16 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2000 | 36 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2000 | 331 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 28 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2011 | 14 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 19 | 0.020 |
Why?
|
| Social Class | 1 | 2003 | 46 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 506 | 0.010 |
Why?
|